MeCure Industries Reports 35.71% Profit Increase for 2026

MeCure Industries Plc has announced its unaudited financial results for the nine months ending 30 September 2026, revealing a pre-tax profit of N8.64 billion, marking a 35.71% increase from N6.37 billion in the same period of 2025. This growth was fueled by a 17.05% rise in revenue, reaching N70.24 billion, compared to N60.01 billion in 2025.

The company's profitability was bolstered by a 50.87% reduction in marketing expenses, which fell to N1.30 billion from N2.64 billion. Consequently, profit after tax also rose by 35.71% to N6.05 billion, up from N4.46 billion, with earnings per share increasing by 36.04% to N1.51 from N1.11.

The performance was primarily driven by stronger sales in acute medicines, over-the-counter products, and narcotics. Despite a 32.99% rise in finance costs to N8.84 billion, operating profit increased by 34.32% to N17.49 billion.

As of 28 October 2026, MeCure's share price remained unchanged at N56.20, reflecting a year-to-date decline of 13.80%.